Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre studyOlga Nigro, Corrado Ficorella, Graziella Pinotti et al.|European Journal of Cancer|2020Cited by 71
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Maria Belen Delany, Matteo Lambertini et al.|Therapeutic Advances in Medical Oncology|2021Cited by 7
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre studyOlga Nigro, Corrado Ficorella, Graziella Pinotti et al.|medRxiv|2020Cited by 6